We are N-[3-(methylamino)propyl]oxolane-2-carboxamide CAS:81403-67-0 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
Chemical Name: N-[3-(methylamino)propyl]oxolane-2-carboxamide
Tetrahydrofuran-2-carboxylic acid (3-methylaminopropyl)amide
Molecular Weight: 186.25100
Physical and Chemical Properties:
Boiling point: 380.81ºC at 760 mmHg
Refractive index: 1.477
25kg cardboard drum or according to customer specified requirements
Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Intermediates of Alfuzosin hydrochloride CAS: 81403-68-1
Related News: Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.Cyanoacetic acid The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers.(6S)-5-Azaspiro[2.4]heptane-5,6-dicarboxylic acid 5-(1,1-dimethylethyl) ester potassium salt In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .9- (4-broMofenil) -10- (naftalen-1-il) antraceno CAS:1160506-32-0 Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.